Phytoalexins: Sources and Their Pharmacological Potential

Rakesh K  Sindhu; Bhavika  Arora; Sandeep  Arora

doi:10.15415/jptrm.2020.81001

Authors

Rakesh K Sindhu Chitkara College of Pharmacy, Chitkara University, Punjab-140401, India
Bhavika Arora Chitkara College of Pharmacy, Chitkara University, Punjab-140401, India
Sandeep Arora Chitkara College of Pharmacy, Chitkara University, Punjab-140401, India

DOI:

https://doi.org/10.15415/jptrm.2020.81001

Keywords:

Phytoalexins, Resveratrol, Anti-Diabetic, Anti-Cancer, Cardio-Protective, Neuro-Protective

Abstract

Background: Plants are easily prone towards microbial infections on exposure to microorganisms and pathogens. In order to defense, plants produce low molecular weight secondary metabolites which were later known as “Phytoalexins”. These molecules have vast therapeutic potential also.
Purpose: The purpose of this review is to explore the phytoalexins and their pharmacological effects.
Methods: The data included from the articles were published from Web of Science, PubMed, Medline, Scopus, and Embase by using relevant keywords including plants possessing phytoalexins and their specific biological applications.
Results: The review insights the potential of phytoalexins in various diseases and to explore phytoalexins applications in human health and disease control.
Conclusions: On the basis of this review it may be concluded that phytoalexins have tremendous potential in the treatment and prevention of various life-threatening diseases like diabetes mellitus, cancer, brain damage, and heart attack.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Abdel-Latif, G.A., Al-Abd, A.M., Tadros, M.G., Al-Abbasi, F.A., Khalifa, A.E., & Abdel-Naim, A.B. (2015). The chemomodulatory effects of resveratrol and didox on herceptin cytotoxicity in breast cancer cell lines. Scientific reports, 5, 12054.

https://doi.org/10.1038/srep12054

Aktaş, H.S., Ozel, Y., Ahmad, S., Pençe, H.H., Ayaz-Adakul, B., Kudas, I., Tetik, S., Sekerler, T., Canbey-Goret, C., Kabasakal, L., & Elcioglu, H.K. (2019). Protective effects of resveratrol on hepatic ischemia reperfusion injury in streptozotocin-induced diabetic rats. Molecular and Cellular Biochemistry, 460(1-2), 217-224. https://doi.org/10.1007/s11010-019-03582-z

Bavaresco, L.U.I.G.I. (2003). Role of viticultural factors on stilbene concentrations of grapes and wine. Drugs Under Experimental and Clinical Research, 29(5-6), 181-187.

Boue, S.M., Cleveland, T.E., Carter-Wientjes, C., Shih, B.Y., Bhatnagar, D., McLachlan, J.M., & Burow, M.E. (2009). Phytoalexin-enriched functional foods. Journal of Agricultural and Food Chemistry, 57(7), 2614-2622. https://doi.org/10.1021/jf8040403

Browne, L.M., Conn, K.L., Ayert, W.A., & Tewari, J.P. (1991). The camalexins: new phytoalexins produced in the leaves of Camelina sativa (Cruciferae). Tetrahedron, 47(24), 3909-3914. https://doi.org/10.1016/S0040-4020(01)86431-0

Coxon, D.T., O’Neill, T.M., Mansfield, J.W., & Porter, A.E.A. (1980). Identification of three hydroxyflavan phytoalexins from daffodil bulbs. Phytochemistry, 19(5), 889-891. https://doi.org/10.1016/0031-9422(80)85132-6

Egbuonu, A.C.C., & Eneogwe, J.C. (2018). Phytoalexins: Current and possible future applications in human health and diseases control. International Journal of Molecular Biology: Open Access, 3(3), 107-112. https://doi.org/10.15406/ijmboa.2018.03.00061

Geigert, J., Stermitz, F.R., Johnson, G., Maag, D.D., & Johnson, D.K. (1973). Two phytoalexins from sugarbeet (Beta vulgaris) leaves. Tetrahedron, 29(18), 2703-2706. https://doi.org/10.1016/S0040-4020(01)93389-7

Grayer, R.J., & Kokubun, T. (2001). Plant–fungal interactions: the search for phytoalexins and other antifungal compounds from higher plants. Phytochemistry, 56(3), 253-263. https://doi.org/10.1016/S0031-9422(00)00450-7

Hammerschmidt, R. (1999). Phytoalexins: what have we learned after 60 years? Annual Review of Phytopathology, 37(1), 285-306. https://doi.org/10.1146/annurev.phyto.37.1.285

Hamadi, N., Mansour, A., Hassan, M.H., Khalifi-Touhami, F., & Badary, O. (2012). Ameliorative effects of resveratrol on liver injury in streptozotocin-induced rats. Journal of Biochemical and Molecular Toxicology, 26(10), 384-392. https://doi.org/10.1002/jbt.21432

Huang, D.-D., Shi, G., Jiang, Y., Yao, C., & Zhu, C. (2020). A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications. Biomedicine & Pharmacotherapy, 125, 109767. https://doi.org/10.1016/j.biopha.2019.109767

Jeandet, P., Clément, C., Courot, E., & Cordelier, S. (2013). Modulation of phytoalexin biosynthesis in engineered plants for disease resistance. International Journal of Molecular Sciences, 14(7), 14136-14170. https://doi.org/10.3390/ijms140714136

Jeandet, P., Hébrard, C., Deville, M.-A., Cordelier, S., Dorey, S., Aziz, A., & Crouzet, J. (2014). Deciphering the role of phytoalexins in plant-microorganism interactions and human health. Molecules, 19(11), 18033-18056. https://doi.org/10.3390/molecules191118033

Jing, Y., Zhaoyang, R., & Jing, C. (2005). A Promising Secondary Metabolite-Resveratrol [J]. Chinese Agricultural Science Bulletin, 7.

Kello, M., Drutovic, D., Chripkova, M., Pilatova, M., Budovska, M., Kulikova, L., Urdzik, P., & Mojzis, J. (2014). ROS-dependent antiproliferative effect of brassinin derivative homobrassinin in human colorectal cancer Caco2 cells. Molecules, 19(8), 10877-10897. https://doi.org/10.3390/molecules190810877

Kim, Y.H., Kim, Y.S., Roh, G.S., Choi, W.S., & Cho, G.J. (2012). Resveratrol blocks diabetes-induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas. Acta Ophthalmologica, 90(1), e31-e37. https://doi.org/10.1111/j.1755-3768.2011.02243.x

Kiskova, T., Kubatka, P., Büsselberg, D., & Kassayova, M. (2020). The Plant-Derived Compound Resveratrol in Brain Cancer: A Review. Biomolecules, 10(1), 161. https://doi.org/10.3390/biom10010161

Ko, J.-C., Syu, J.-J., Chen, J.-C., Wang, T.-J., Chang, P.-Y., Chen, C.-Y., Jian, Y.-T., Jian, Y.-J., & Lin, Y.W. (2015). Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK 1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC 1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells. Basic & Clinical

Pharmacology & Toxicology, 117(6), 383-391. https://doi.org/10.1111/bcpt.12425

Kumar, A., Kaundal, R.K., Iyer, S., & Sharma, S.S. (2007). Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sciences, 80(13), 1236-1244. https://doi.org/10.1016/j.lfs.2006.12.036

Langcake, P., & Pryce, R.J. (1976). The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiological Plant Pathology, 9(1), 77-86. https://doi.org/10.1016/0048-4059(76)90077-1

Lozano-Mena, G., Sánchez-González, M., Juan, M.E., & Planas, J.M. (2014). Maslinic acid, a natural phytoalexin-type triterpene from olives—a promising nutraceutical? Molecules, 19(8), 11538-11559. https://doi.org/10.3390/molecules190811538

Ma, L., Li, W., Wang, R., Nan, Y., Wang, Q., Liu, W., & Jin, F. (2015). Resveratrol enhanced anticancer effects of cisplatin on non-small cell lung cancer cell lines by inducing mitochondrial dysfunction and cell apoptosis. International Journal of Oncology, 47(4), 1460-1468. https://doi.org/10.3892/ijo.2015.3124

Mehta, R.G., Liu, J., Constantinou, A., Thomas, C. F., Hawthorne, M., You, M., Gerhauser, C., Pezzuto, J.M., Moon, R.C., & Moriarty, R.M. (1995). Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage. Carcinogenesis, 16(2), 399-404. https://doi.org/10.1093/carcin/16.2.399

Mohapatra, P., Satapathy, S.R., Das, D., Siddharth, S., Choudhuri, T., & Kundu, C. N. (2014). Resveratrol mediated cell death in cigarette smoke transformed breast epithelial cells is through induction of p21Waf1/Cip1 and inhibition of long patch base excision repair pathway. Toxicology and Applied Pharmacology, 275(3), 221-231. https://doi.org/10.1016/j.taap.2014.01.011

Öztürk, E., Arslan, A.K.K., Yerer, M.B., & Bishayee, A. (2017). Resveratrol and diabetes: A critical review of clinical studies. Biomedicine & Pharmacotherapy, 95, 230-234. https://doi.org/10.1016/j.biopha.2017.08.070

Pallàs, M., Casadesús, G., Smith, M.A., Coto-Montes, A., Pelegri, C., Vilaplana, J., & Camins, A. (2009). Resveratrol and neurodegenerative diseases: Activation of SIRT1 as the potential pathway towards neuroprotection. Current Neurovascular Research, 6(1), 70-81. https://doi.org/10.2174/156720209787466019

Pedras, M.S.C., Zheng, Q.-A., & Sarma-Mamillapalle, V.K. (2007). The phytoalexins from Brassicaceae: structure, biological activity, synthesis and biosynthesis. Natural Product Communications, 2(3), 319-330. https://doi.org/10.1177/1934578X0700200315

Pedras, M.S.C., Adio, A.M., Suchy, M., Okinyo, D.P.O., Zheng, Q.A., Jha, M., & Sarwar, M.G. (2006). Detection, characterization and identification of crucifer phytoalexins using high-performance liquid chromatography with diode array detection and electrospray ionization mass spectrometry. Journal of Chromatography A, 1133(1-2), 172-183. https://doi.org/10.1016/j.chroma.2006.08.015

Rauf, A., Imran, M., Butt, M.S., Nadeem, M., Peters, D.G., & Mubarak, M.S. (2018). Resveratrol as an anticancer agent: A review. Critical Reviews in Food Science and Nutrition, 58(9), 1428-1447. https://doi.org/10.1080/10408398.2016.1263597

Riles, W.L., Erickson, J., Nayyar, S., Atten, M.J., Attar, B.M., & Holian, O. (2006). Resveratrol engages selective apoptotic signals in gastric adenocarcinoma cells. World Journal of Gastroenterology, 12(35), 5628-5634. https://doi.org/10.3748/wjg.v12.i35.5628

Rocha-González, H.I., Ambriz-Tututi, M., & Granados-Soto, V. (2008). Resveratrol: A natural compound with pharmacological potential in neurodegenerative diseases. CNS Neuroscience & Therapeutics, 14(3), 234-247. https://doi.org/10.1111/j.1755-5949.2008.00045.x

Sen, S. (2017). Role of Phytoalexins in Plant-Microbe Interactions and Human Health. International Journal of Scientific Research and Management, 5(7), 6215-6225. https://doi.org/10.18535/ijsrm/v5i7.52

Sharma, S., Kulkarni, S.K., & Chopra, K. (2007). Effect of resveratrol, a polyphenolic phytoalexin, on thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Fundamental & Clinical Pharmacology, 21(1), 89-94. https://doi.org/10.1111/j.1472-8206.2006.00455.x

Sitton, D., & West, C.A. (1975). Casbene: An anti-fungal diterpene produced in cell-free extracts of Ricinus communis seedlings. Phytochemistry, 14(9), 1921-1925. https://doi.org/10.1016/0031-9422(75)83098-6

Smith, B., Randle, D., Mezencev, R., Thomas, L., Hinton, C., & Odero-Marah, V. (2014). Camalexin-induced apoptosis in prostate cancer cells involves alterations of expression and activity of lysosomal protease cathepsin D. Molecules, 19(4), 3988-4005. https://doi.org/10.3390/molecules19043988

Soufi, F.G., Mohammad-nejad, D., & Ahmadieh, H. (2012). Resveratrol improves diabetic retinopathy possibly through oxidative stress—Nuclear factor κb—Apoptosis pathway. Pharmacological Reports, 64(6), 1505-1514. https://doi.org/10.1016/S1734-1140(12)70948-9

Sunilkumar, G., Campbell, L.M., Puckhaber, L., Stipanovic, R.D., & Rathore, K.S. (2006). Engineering cottonseed for use in human nutrition by tissue-specific reduction of toxic gossypol. Proceedings of the National Academy of Sciences, 103(48), 18054-18059. https://doi.org/10.1073/pnas.0605389103

Ward, E.W.B., Unwin, C.H., & Stoessel, A. (1975). Loroglossol: An orchid phytoalexin. Phytopathology, 65, 632–633.

Wen, D., Huang, X., Zhang, M., Zhang, L., Chen, J., Gu, Y., & Hao, C.-M. (2013). Resveratrol attenuates diabetic nephropathy via modulating angiogenesis. PloS one, 8(12), e82336. https://doi.org/10.1371/journal.pone.0082336

Zheng, G.H., & Li, H.Q. (2008). Effects of garlic oil combined with resveratrol on inducing apoptosis and expression of Fas, bcl-2 and bax in human gastric cancer cell line. Zhonghua yu Fang yi xue za zhi [Chinese Journal of Preventive Medicine], 42(1), 39-42.